Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Optimizing IBS-D Treatment in Primary Care
Clinician's RoundtableOptimizing IBS-D Treatment in Primary Care
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Mechanisms of Action in IBS-C Therapies: Secretagogues and Serotonergic Agents
GI InsightsMechanisms of Action in IBS-C Therapies: Secretagogues and Serotonergic Agents
Managing Treatment-Resistant IBS-C: Strategies to Address Refractory Symptoms
GI InsightsManaging Treatment-Resistant IBS-C: Strategies to Address Refractory Symptoms
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE Live BroadcastInnovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
May 04, 2025
09:30 PM - 10:30 PM ET
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Objective Measures and Endoscopic Improvement
Medical Industry FeatureObjective Measures and Endoscopic Improvement
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
Medical Industry FeatureEmerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
- nature.com04/22/2025
- 04/17/2025
- 04/15/2025
- 04/14/2025
- 04/14/2025
- 04/11/2025
nature.com